Mesenchymal stem cells reduce left ventricular mass in rats with doxorubicin-induced cardiomyopathy
Haydardedeoglu, Ali Evren; Boztok Özgermen, Deva Basak; Yavuz, Orhan.
Int. j. morphol
; 36(1): 48-53, Mar. 2018. tab, graf
Artigo em Inglês | LILACS | ID: biblio-893185
Functional and Structural Assessment of the Effect of Human Umbilical Cord Blood Mesenchymal Stem Cells in Doxorubicin-Induced Cardiotoxicity.
Estudo clínico e de fatores de risco associados às alterações cardiovasculares em cães
Anatomopathological study of cardiomyopathy induced by doxorubicin in rats
Anthracycline-mediated cardiomyopathy: Basic molecular knowledge for the cardiologist
Biophysical Derangements in Genetic Cardiomyopathies.
Controversies Surrounding Exercise in Genetic Cardiomyopathies.
Histamine 2 receptor antagonism elicits protection against doxorubicin-induced cardiotoxicity in rodent model.
Genomic correction of familial cardiomyopathy in human engineered cardiac tissues.
From molecular mechanism to morphological changes in cardiomyopathy.
Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.